Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387332564> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4387332564 endingPage "424" @default.
- W4387332564 startingPage "424" @default.
- W4387332564 abstract "<ns4:p>The cornerstone of inflammatory bowel disease (IBD) treatment is immunomodulators. IBD patients are at increased risk of intestinal and extraintestinal malignancy. Ustekinumab is a fully humanized monoclonal anti-IL12/23 antibody with a good safety profile. Malignancies of breast, colon, head and neck, kidney, prostate, thyroid, and non-melanoma skin cancer have been reported among patients who received ustekinumab. We report the case of a 42-year-old Crohn’s patient on long-term treatment with ustekinumab, who developed achromatic malignant melanoma. Crohn’s was diagnosed at the age of 15, with upper and lower gastrointestinal involvement and was initially treated with azathioprine (2mg/kg for 4 years) and infliximab (5mg/kg for 6 weeks). Due to ileal obstruction, the patient underwent stricturoplasty and received adalimumab (40mg every other week) for two years. He then discontinued therapy and a year later underwent right hemicolectomy. Adalimumab was reinstituted (40mg every other week) and the patient remained in clinical remission for two years. His overall exposure to adalimumab was four years. Ustekinumab was initiated due to a relapse and after 3 years, an incident of scalp itching led to the diagnosis metastatic achromatic malignant melanoma bearing BRAF V600E mutation. He received targeted therapy with an initial good response. We aim to point out the risk of dermatologic malignancy in IBD patients on long-term immunosuppression and the lifelong and meticulous evaluation that is required.</ns4:p>" @default.
- W4387332564 created "2023-10-05" @default.
- W4387332564 creator A5014142214 @default.
- W4387332564 creator A5036267976 @default.
- W4387332564 creator A5038092500 @default.
- W4387332564 creator A5057015705 @default.
- W4387332564 creator A5075922494 @default.
- W4387332564 creator A5078331917 @default.
- W4387332564 creator A5090683107 @default.
- W4387332564 date "2023-10-04" @default.
- W4387332564 modified "2023-10-14" @default.
- W4387332564 title "Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumab" @default.
- W4387332564 cites W1543684037 @default.
- W4387332564 cites W1573058660 @default.
- W4387332564 cites W1973977312 @default.
- W4387332564 cites W2013637937 @default.
- W4387332564 cites W2015336843 @default.
- W4387332564 cites W2024763754 @default.
- W4387332564 cites W2071030284 @default.
- W4387332564 cites W2097733438 @default.
- W4387332564 cites W2104081595 @default.
- W4387332564 cites W2106865732 @default.
- W4387332564 cites W2112639375 @default.
- W4387332564 cites W2412534997 @default.
- W4387332564 cites W2614318748 @default.
- W4387332564 cites W2738401183 @default.
- W4387332564 cites W2758711729 @default.
- W4387332564 cites W2900046418 @default.
- W4387332564 cites W2911723829 @default.
- W4387332564 cites W2948049516 @default.
- W4387332564 cites W3028017255 @default.
- W4387332564 cites W3049225255 @default.
- W4387332564 cites W3128770501 @default.
- W4387332564 doi "https://doi.org/10.12688/f1000research.110356.2" @default.
- W4387332564 hasPublicationYear "2023" @default.
- W4387332564 type Work @default.
- W4387332564 citedByCount "0" @default.
- W4387332564 crossrefType "journal-article" @default.
- W4387332564 hasAuthorship W4387332564A5014142214 @default.
- W4387332564 hasAuthorship W4387332564A5036267976 @default.
- W4387332564 hasAuthorship W4387332564A5038092500 @default.
- W4387332564 hasAuthorship W4387332564A5057015705 @default.
- W4387332564 hasAuthorship W4387332564A5075922494 @default.
- W4387332564 hasAuthorship W4387332564A5078331917 @default.
- W4387332564 hasAuthorship W4387332564A5090683107 @default.
- W4387332564 hasBestOaLocation W43873325641 @default.
- W4387332564 hasConcept C126322002 @default.
- W4387332564 hasConcept C141071460 @default.
- W4387332564 hasConcept C16005928 @default.
- W4387332564 hasConcept C2777138892 @default.
- W4387332564 hasConcept C2778975655 @default.
- W4387332564 hasConcept C2779134260 @default.
- W4387332564 hasConcept C2779280984 @default.
- W4387332564 hasConcept C2779399171 @default.
- W4387332564 hasConcept C2780132546 @default.
- W4387332564 hasConcept C2780252810 @default.
- W4387332564 hasConcept C71924100 @default.
- W4387332564 hasConcept C90924648 @default.
- W4387332564 hasConceptScore W4387332564C126322002 @default.
- W4387332564 hasConceptScore W4387332564C141071460 @default.
- W4387332564 hasConceptScore W4387332564C16005928 @default.
- W4387332564 hasConceptScore W4387332564C2777138892 @default.
- W4387332564 hasConceptScore W4387332564C2778975655 @default.
- W4387332564 hasConceptScore W4387332564C2779134260 @default.
- W4387332564 hasConceptScore W4387332564C2779280984 @default.
- W4387332564 hasConceptScore W4387332564C2779399171 @default.
- W4387332564 hasConceptScore W4387332564C2780132546 @default.
- W4387332564 hasConceptScore W4387332564C2780252810 @default.
- W4387332564 hasConceptScore W4387332564C71924100 @default.
- W4387332564 hasConceptScore W4387332564C90924648 @default.
- W4387332564 hasLocation W43873325641 @default.
- W4387332564 hasOpenAccess W4387332564 @default.
- W4387332564 hasPrimaryLocation W43873325641 @default.
- W4387332564 hasRelatedWork W2284300818 @default.
- W4387332564 hasRelatedWork W2414272582 @default.
- W4387332564 hasRelatedWork W2914662974 @default.
- W4387332564 hasRelatedWork W2960758672 @default.
- W4387332564 hasRelatedWork W3207621403 @default.
- W4387332564 hasRelatedWork W4255520715 @default.
- W4387332564 hasRelatedWork W4353047497 @default.
- W4387332564 hasRelatedWork W4367728861 @default.
- W4387332564 hasRelatedWork W4381125750 @default.
- W4387332564 hasRelatedWork W4383421022 @default.
- W4387332564 hasVolume "11" @default.
- W4387332564 isParatext "false" @default.
- W4387332564 isRetracted "false" @default.
- W4387332564 workType "article" @default.